East Brunswick, NJ – According to filings with the U.S. Securities and Exchange Commission, DiRx is raising $9,009,600.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Satish Srinivasan played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About DiRx
DiRx is an online pharmacy platform that delivers savings on commonly prescribed, FDA-approved generic medicines without the need for insurance. Founded by industry experts, DiRx draws a straight line from supply to demand to streamline the path between the manufacturer and the consumer. This lowers costs and makes more medicine accessible to more people. DiRx offers a viable model for businesses and community organizations while simplifying how consumers fill, pay for and receive maintenance medicines.

To learn more about DiRx, visit http://www.dirxhealth.com/

Contact:
Satish Srinivasan, Chief Executive Officer
877-367-3479
satish.srinivasan@dirxhealth.com
https://www.linkedin.com/in/satishsri/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved